Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly

Stem Cell Research and Therapy

Volumn 5, Issue 2, 2014, Pages

  Amable, Paola Romina ^a   Teixeira, Marcus Vinicius Telles ^a,b   Carias, Rosana Bizon Vieira ^a,b   Granjeiro, José Mauro ^b   Borojevic, Radovan ^a,b  

^a Excellion Biomedical Services SA   (Brazil)

^b INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL SURFACE MARKER; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR AB; RANTES; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL PROLIFERATION; CHONDROGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; WHARTON JELLY; ANIMAL; BONE MARROW CELL; BOVINE; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

BOVINAE;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PROTEIN BIOSYNTHESIS; WHARTON JELLY;

EID: 84901016324     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt442     Document Type: Article

References (47)

1. A perivascular origin for mesenchymal stem cells in multiple human organs. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Péault B, Cell Stem Cell 2008 13 301 313
2. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Friedenstein J, Chailakhjan RK, Lalykina KS, Cell Tissue Kinet 1970 3 393 403 5523063
3. Multilineage cells from human adipose tissue: implications for cell-based therapies. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH, Tissue Eng 2001 7 211 228 10.1089/107632701300062859 11304456 (Pubitemid 32295155)
4. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, Zhang X, Cell Biol Int 2006 30 681 687 10.1016/j.cellbi.2006. 03.009 16870478 (Pubitemid 44331625)
5. Stem cells of the alveolar epithelium. Griffiths MJ, Bonnet D, Janes SM, Lancet 2005 366 249 260 10.1016/S0140-6736(05)66916-4 16023517 (Pubitemid 40981054)
6. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC, Stem Cells 2004 22 1330 1337 10.1634/stemcells.2004-0013 15579650 (Pubitemid 39636408)
7. Multipotent mesenchymal stem cells from adult human synovial membrane. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP, Arthritis Rheum 1928-1942 2001 44
8. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S, Proc Natl Acad Sci U S A 2000 97 13625 13630 10.1073/pnas.240309797 11087820
9. Molecular mechanisms of migration and homing of intravenously transplanted mesenchymal stem cells. Kholodenko IV, Konieva AA, Kholodenko RV, Yarygin KN, J Regen Med Tissue Eng 2013 2 4 11 10.7243/2050-1218-2-4
10. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Galindo LT, Filippo TR, Semedo P, Ariza CB, Moreira CM, Camara NO, Porcionatto MA, Neurol Res Int 2011 2011 564089 21766025
11. Engraftment of human nasal olfactory stem cells restores neuroplasticity in mice with hippocampal lesions. Nivet E, Vignes M, Girard SD, Pierrisnard C, Baril N, Devèze A, Magnan J, Lanté F, Khrestchatisky M, Féron F, Roman FS, J Clin Invest 2011 121 2808 2820 10.1172/JCI44489 21670501
12. Bang OY; STARTING collaborators: A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Stem Cells 2012 28 1099 1106
13. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O, Exp Hematol 2003 31 890 896 10.1016/S0301- 472X(03)00110-3 14550804 (Pubitemid 37211373)
14. Mesenchymal stem cells avoid allogeneic rejection. Ryan JM, Barry FP, Murphy JM, Mahon BP, J Inflamm (Lond) 2005 2 8 10.1186/1476-9255-2-8 16045800 (Pubitemid 41364607)
15. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, Prigione A, Adjaye J, Kassem M, Aldahmash A, Stem Cell Rev 2013 9 32 43 10.1007/s12015-012-9365-8 22529014
16. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T, Arthritis Rheum 2005 52 2521 2529 10.1002/art.21212 16052568 (Pubitemid 41117441)
17. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Wang L, Tran I, Seshareddy K, Weiss ML, Detamore MS, Tissue Eng Part A 2009 15 2259 2266 10.1089/ten.tea.2008.0393 19260778
18. Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts. Ramkisoensing AA, Pijnappels DA, Askar SFA, Passier R, Swildens J, Goumans MJ, Schutte CI, de Vries AA, Scherjon S, Mummery CL, Schalij MJ, Atsma D, PLoS ONE 2011 6 24164 10.1371/journal.pone.0024164 21931658
19. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee IH, Li WS, Wu CH, Lin WY, Cheng SM, PLoS ONE 2013 8 72604 10.1371/journal.pone.0072604 23991127
20. The origin of human mesenchymal stromal cells dictates their reparative properties. Naftali-Shani N, Itzhaki-Alfia A, Landa-Rouben N, Kain D, Holbova R, Adutler-Lieber S, Molotski N, Asher E, Grupper A, Millet E, Tessone A, Winkler E, Kastrup J, Feinberg MS, Zipori D, Pevsner-Fischer M, Raanani E, Leor J, J Am Heart Assoc 2013 2 000253 24080908
21. Identification of appropriate reference genes for human mesenchymal cells during expansion and differentiation. Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R, PLoS One 2013 8 73792 10.1371/journal.pone.0073792 24023904
22. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW, Stem Cells Dev 1895-1910 2010 19
23. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S, Cell Transplant 2011 20 655 667 10.3727/096368910X536473 21054940
24. Stem cell therapy for neonatal diseases associated with preterm birth. Borghesi A, Cova C, Gazzolo D, Stronati M, J Clin Neonatol 2013 2 1 7 10.4103/2249-4847.109230 24027735
25. Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential. Messerli M, Wagner A, Sager R, Mueller M, Baumann M, Surbek DV, Schoeberlein A, Reprod Sci 2013 20 1455 1464 10.1177/1933719113488443 23670950
26. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW, Blood 2005 106 584 592 10.1182/blood-2004-12-4942 15811956 (Pubitemid 40981255)
27. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC, Stem Cells 2010 28 788 798 10.1002/stem.312 20127798
28. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH, Circulation 2000 101 1767 1772 10.1161/01.CIR.101.15.1767 10769275 (Pubitemid 30213096)
29. Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege. Li P, Li SH, Wu J, Zang WF, Dhingra S, Sun L, Weisel RD, Li RK, J Cell Mol Med 2013 17 1136 1145 23802625
30. Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. Pricola KL, Kuhn NZ, Haleem-Smith H, Song Y, Tuan RS, J Cell Biochem 2009 108 577 588 10.1002/jcb.22289 19650110
31. Mesenchymal stem cells and interleukin-6 attenuate liver fibrosis in mice. Nasir GA, Mohsin S, Khan M, Shams S, Ali G, Khan SN, Riazuddin S, J Transl Med 2013 11 78 10.1186/1479-5876-11-78 23531302
32. Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice. Sandberg JO, Andersson A, Eizirik DL, Sandler S, Biochem Biophys Res Commun 1994 202 543 548 10.1006/bbrc.1994.1962 8037760
33. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG, Proc Natl Acad Sci U S A 2007 104 11002 11007 10.1073/pnas.0704421104 17569781 (Pubitemid 47175216)
34. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, Ludlow JW, Stricker DM, Potiny S, Green P, Halvorsen YD, Cheatham B, Storms RW, Gimble JM, J Cell Physiol 2007 212 702 709 10.1002/jcp.21068 17477371 (Pubitemid 47271882)
35. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholová I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Ylä-Herttuala S, Circ Res 2003 92 1098 1106 10.1161/01.RES.0000073584.46059.E3 12714562 (Pubitemid 36665855)
36. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S, Circulation 2009 120 247 S254 10.1161/CIRCULATIONAHA.108.843680 19752375
37. VEGF overexpression improves mesenchymal stem cell sheet transplantation therapy for acute myocardial infarction. Augustin M, Mahar MA, Lakkisto P, Tikkanen I, Vento A, Pätilä T, Harjula A, J Tissue Eng Regen Med 2013 7 742 750 10.1002/term.1471
38. Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation. Jeong SY, Kim DH, Ha J, Jin HJ, Kwon SJ, Chang JW, Choi SJ, Oh W, Yang YS, Kim G, Kim JS, Yoon JR, Cho DH, Jeon HB, Stem Cells 2013 31 2136 2148 10.1002/stem.1471 23843355
39. Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction. Paul A, Nayan M, Khan AA, Shum-Tim D, Prakash S, Int J Nanomedicine 2012 7 663 682 10.2217/nnm.11.130 22334788
40. Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Liu XB, Jiang J, Gui C, Hu XY, Xiang MX, Wang JA, Acta Pharmacol Sin 2008 29 815 822 10.1111/j.1745-7254.2008.00811.x 18565279
41. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, Kocsis JD, Brain 2006 129 2734 2745 10.1093/brain/awl207 16901914 (Pubitemid 44522106)
42. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, Fiaccavento R, Carotenuto F, De Vito P, Baldini PM, Prat M, Di Nardo P, Stem Cells 2006 24 23 33 10.1634/stemcells.2004-0176 16100005
43. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, Ogawa S, Okano H, Hotta T, Ando K, Fukuda K, Blood 2004 104 3581 3587 10.1182/blood-2004-04-1488 15297308 (Pubitemid 39564430)
44. Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Deng J, Zou ZM, Zhou TL, Su YP, Ai GP, Wang JP, Xu H, Dong SW, Neurol Sci 2011 32 641 651 10.1007/s10072-011-0608-2 21678074
45. Role of PDGF-BB in the behavior of mesenchymal stem cells in human skin. Soma T, Yamanishi H, Ishimatsu-Tsuji Y, Fujiwara S, J Invest Dermatol 2012 132 135 S148
46. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, López-Otín C, Arthritis Rheum 1997 40 1391 1399 10.1002/art.1780400806 9259418 (Pubitemid 27430949)
47. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH, Ital J Biochem 2005 54 248 257 16688934